New Gene Therapies Could Change Hemophilia Forever – Motley Fool
|
New Gene Therapies Could Change Hemophilia Forever
Motley Fool At last week's American Society of Hemophilia conference, Spark Therapeutics (NASDAQ:ONCE) and BioMarin (NASDAQ:BMRN) presented promising data for gene therapy drugs that could change the way hemophilia is treated, making patients' lives significantly … |
